Definitive Contract 75D30121C10795
Award Date
4/28/21
Potential Completion Date
4/15/22
Potential Value
$40M
Federal Agency
CDC Pittsburgh
Awardee
Aegis Sciences Corporation
Ultimate Awardee
Not listed
NAICS Category
621511 - Medical Laboratories
PSC Category
Q301 - Reference Laboratory Testing
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Nashville, TN 37228, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Health and Human Services Centers for Disease Control and Prevention in Pittsburgh awarded a $1.2 million firm fixed price purchase order to Aegis Sciences Corporation of Nashville, Tennessee for genomic sequencing services. As the prime contractor, Aegis Sciences Corporation will perform the sequencing under its Aegis Analytical Laboratories division. The contract runs from March 1, 2021 through April 15, 2021 to support genomic sequencing efforts at the CDC, likely related to...
The Centers for Disease Control and Prevention awarded a $600,000 firm fixed price purchase order to Illumina, Inc. of San Diego, California. The contract calls for SARS-COV-2 SPHERES baseline genomic sequencing in support of the CDC's coronavirus COVID-19 programs. Performance will take place in San Diego through March 2021. As the leading public health agency in the U.S., the CDC routinely sequences virus genomes to track disease spread and evolution, providing genomic surveillance critical...
The Centers for Disease Control and Prevention awarded a $3.975 million firm fixed price definitive contract to Illumina, Inc. of San Diego, California. The contract is for SARS-COV-2 SPHERES Baseline Genomic Sequencing to support the Department of Health and Human Services and CDC's efforts responding to the Coronavirus Disease 2019 (COVID-19) pandemic. Under this contract, Illumina will provide genomic sequencing and data analysis services to establish a baseline of SARS-CoV-2 virus genomes...
The Centers for Disease Control and Prevention (CDC) awarded a sole source firm fixed price contract to The Broad Institute, Inc. to provide genomic sequencing of up to 5,000 SARS-CoV-2 samples per week from various jurisdictions. The contract has a potential value of $15,763,600.00 and includes two 13-week option periods to potentially sequence up to 10,000 samples per week. The Broad Institute, a non-profit research organization, will sequence the samples and submit the data to public...
This is a delivery order awarded by the Centers for Disease Control and Prevention (CDC) to Aegis Sciences Corporation, a forensic toxicology and healthcare laboratory company, for a Test Surge and Data Sharing multiple-award indefinite-delivery, indefinite-quantity (IDIQ) contract. The delivery order, valued at $610,000.00, will task Aegis to provide science-driven drug testing and consulting services, including COVID-19 testing, genomic sequencing, and variant tracking out of its Nashville,...
This firm fixed price delivery order was awarded by the National Heart, Lung, and Blood Institute (NHLBI), a civilian agency, to Aegis Sciences Corporation, a for-profit organization, to provide genotyping services for tracking viral variants. The order, valued at $17,771,325.00, is a task order under an existing indefinite delivery contract between NHLBI and Aegis potentially worth $47.97 million to perform viral variant genotyping work. The work will be conducted at Aegis' facility in...
The Centers for Disease Control and Prevention (CDC) awarded a $8,587,890.00 firm fixed price definitive contract to Quest Diagnostics Nichols Institute, doing business as Quest Diagnostics, for genomic sequencing services. The contract supports the CDC's disease prevention and health promotion efforts through genomic surveillance of viruses like COVID-19. This contract does not have a set-aside designation. Quest Diagnostics Nichols Institute, a subsidiary of the parent company Quest...
This is a $13,031,850.00 firm-fixed price definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to Laboratory Corporation of America (LabCorp) for genomic sequencing services. The contract has an ultimate completion date of May 14, 2022 and was awarded on December 26, 2021. LabCorp is a leading global life sciences company that provides diagnostic information services. They have extensive experience contracting with the federal government, including through their...
The Centers for Disease Control and Prevention (CDC) awarded a firm-fixed-price purchase order to Illumina, Inc. for $128,657.11 to provide whole genome sequencing kits. The award has an ultimate completion date of September 30, 2024. This award was made under an unrestricted solicitation, RFQ 75D301-24-Q-77983, which sought commercial items related to whole genome sequencing for antimicrobial resistance surveillance, including NovaSeq 6000 SP Reagent Kits, NovaSeq XP 2-Lane Kits, ILMN DNA LP...
This is a $1,074,709 firm fixed-price definitive contract awarded to the Translational Genomics Research Institute (TGen), a non-profit research organization, by the Centers for Disease Control and Prevention (CDC) for the FY 21 BAA TOPIC 8 - TGRI project. The contract has a period of performance through May 14, 2023 and was awarded on May 15, 2021 with no set-aside designation. TGen is a leading institute in precision medicine and translational bioscience, specializing in genomic analyses,...